Together, these data suggest that although YAP/TAZ inhibition suppresses lung cancer cell proliferation, it confers resistance to ferroptosis, which may contribute to the progression of tumors exhibiting heterogeneous activation statuses of YAP/TAZ. The gene discussed is YAP1; the disease is lung cancer.